Katsuyuki Fukushima

发表

Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry

S. Kochen, A. Carius, B. Steinhoff, 2018, The Lancet Neurology.

A Nonsense Mutation of the Sodium Channel Gene SCN2A in a Patient with Intractable Epilepsy and Mental Decline

K. Yamakawa, N. Makita, M. Montal, 2004, The Journal of Neuroscience.

Stiripentol open study in Japanese patients with Dravet syndrome

S. Ikeda, J. Tohyama, H. Oguni, 2009, Epilepsia.

Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy

K Fukushima, K. Yamakawa, Y. Inoue, 2002, Neurology.

Drop Attacks and Epileptic Syndromes

T. Fujiwara, K. Yagi, M. Seino, 1993, The Japanese journal of psychiatry and neurology.

Vaccination and Infection as Causative Factors in Japanese Patients With Rasmussen Syndrome: Molecular Mimicry and HLA Class I

H. Osaka, A. Imamura, N. Kondo, 2006, Clinical & developmental immunology.

Autoantibodies and Cell‐mediated Autoimmunity to NMDA‐type GluRɛ2 in Patients with Rasmussen's Encephalitis and Chronic Progressive Epilepsia Partialis Continua

Masahiko Watanabe, M. Mishina, A. Imamura, 2005, Epilepsia.

Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures.

Yukitoshi Takahashi, Kazuichi Yagi, Masako Watanabe, 2003, Brain : a journal of neurology.

A Long‐term Follow‐up of Zonisamide Monotherapy

M. Seino, K. Fukushima, Katsuyuki Fukushima, 2006, Epilepsia.

Long‐Term Course of West Syndrome Associated with Tuberous Sclerosis

Y. Inoue, T. Fujiwara, K. Yagi, 1998, Epilepsia.

Initial Clinical Manifestations of Seizures Originating from the Occipital Area

Y. Inoue, K. Yagi, M. Seino, 1987 .